The Autologous Biologics Market was valued at USD 8.5 billion in 2024 and is projected to reach USD 20.1 billion by 2034, registering a CAGR of 9.0%. This growth trajectory is underpinned by several key factors, including the increasing prevalence of chronic diseases, advancements in regenerative medicine, and a growing focus on personalized medicine. The demand for autologous biologics, which...